Concordia Kapvay Extended-Release

Description

Active Ingredient: Active component Clonidine Hydrochloride in the medicine is the hydrochloride salt form of clonidine, an imidazoline derivate, and centrally-acting alpha-adrenergic agonist. It is also antagonist with antihypertensive activity. It binds to and stimulates central alpha-2 adrenergic receptors and decreases sympathetic outflow to the heart, kidneys, and peripheral vasculature. Due to reduction in sympathetic outflow, leads to decrease in peripheral vascular resistance, lowered blood pressure, and decreased heart rate.

Indications: The medicine composed of Clonidine hydrochloride is extended-release tablet. It is indicated for the treatment of attention deficit hyperactivity disorder i.e. ADHD. It is used as monotherapy and as adjunctive therapy to stimulant medications.

Action Mechanism: The exact mechanism of this Kapvay Extended-Release pill is not known. This conventional tablet stimulates alpha-2 receptors in the brain. This may reduce hyperactivity symptoms by acting on parts of the brain that control emotion, attention, and behavior.

Dosages: The extended-release tablet drug Kapvay Extended-Release is used to treat attention deficit hyperactivity disorder. The popular brand of this medicine is available in dosage as:

• 0.1 mg: Consume this tablet twice a day as instructed by the doctor. Do not take it more than prescribed

Note: Consult the doctor before stopping this medication. The doctor may gradually reduce the dosages. Seek immediate medical assistance in case observed any serious allergic reactions. It is advisable to check blood pressure regularly. People with serious heart diseases should not take this pill unless prescribed by the doctor.